Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2013.
|Fourth||Fourth||Year Ended||Year Ended|
|Quarter||Quarter||Dec. 31,||Dec. 31,|
|$ in millions, except EPS amounts||2013||2012||2013||2012|
Non-GAAP EPS that excludes items listed below 1
GAAP Net Income 2
Non-GAAP Net Income that excludes items listed below 1,2
Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88 and $3.49 for the full year of 2013 exclude acquisition-related costs, restructuring costs and certain other items.